-
Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Aetna giving ML the boot?
Discussion in 'Millennium Laboratories' started by Anonymous, Jan 28, 2014 at 4:16 AM.